Autoimmune and inflammatory disorders and risk of malignant lymphomas : an update

• As specific autoimmune disorders now constitute established risk factors for malignant lymphomas, we describe this association.We review reported risk levels, risk determinants, lymphoma subtypes and biological mechanisms in autoimmunity/inflammation, emphasizing on recent findings.Whilst numerous reports describe average lymphoma risks in large patient groups, there's a recent shift of focus to risk determinants and the role of inflammatory activity. Studies highlight associations with diffuse large B-cell lymphoma, apart from lymphoma development in target organs of inflammation.Future studies of high-risk patient subsets using detailed assessments of autoimmunity/inflammation and lymphoma may give important clues to lymphomagenesis.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Autoimmunity

Chronic inflammation

Immune stimulation

Malignant lymphoma

MEDICINE

MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)

for (ämneskategori)